{$XLRN} $BMY receive positive CHMP opinion in the EU for an investigational agent for the treatment of adults with anemia in beta thalassemia and myelodysplastic syndromes #XLRN #Bthal #MDS pleased to announce its therapeutic candidate for the treatment of pulmonary arterial hypertension has been granted PRIME designation by the EMA